Quintrio
Home

Stock overview

Limoneira Co

LMNR

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

Last trade $10.02
Day change +$0.125 (+1.26%)
Day range $9.88 – $10.13
Volume 37,883
Market cap $179M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$179.33M
Price / earnings
—
Price / book
1.36×
Price / sales
1.39×
EV / sales
2.16×
EV / EBITDA
-15.43×

Profitability

Earnings per share
-$2.37
Return on assets
-14.36%
Return on equity
-32.53%
Dividend yield
1.65%

Liquidity and leverage

Debt / equity
0.77×
Current ratio
1.51×
Quick ratio
1.44×
Cash ratio
0.08×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$31.04M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for LMNR, quarterly periods
Line itemQ3 FY2026 Jul 31, 2026Q2 FY2026 Apr 30, 2026Q1 FY2026 Jan 31, 2026Q4 FY2025 Oct 31, 2025Q3 FY2025 Jul 31, 2025Q2 FY2025 Apr 30, 2025Q1 FY2025 Jan 31, 2025Q4 FY2024 Oct 31, 2024
Revenue$43.81M$23.93M$18.21M$42.82M$47.48M$35.12M$34.31M$43.86M
Cost of revenue$38.29M$24.17M$24.09M$48.77M$43.14M$32.71M$34.67M$41.23M
Gross profit$5.52M-$243K-$5.89M-$5.95M$4.34M$2.41M-$365K$2.63M
Selling, general and administrative$4.02M$5.42M$4.59M$7.31M$4.96M$5.73M$6.48M$5.76M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$8.14M$13.63M$4.59M$7.31M$4.96M$5.73M$6.48M$5.76M
Operating income-$2.63M-$13.87M-$10.48M-$13.26M-$615K-$3.33M-$6.84M-$3.13M
Interest expense-$1.11M-$560K-$779K-$655K-$410K-$228K-$260K-$130K
Income before taxes-$3.98M-$27.61M-$12.01M-$11.73M-$734K-$3.06M-$5.48M-$1.6M
Income taxes-$1.03M-$5.28M-$2.7M-$2.73M$182K$301K-$2.41M$322K
Net income-$2.95M-$22.32M-$9.31M-$9M-$916K-$3.37M-$3.07M-$1.92M
Net income attributable to common shareholders-$3.12M-$21.55M-$9.55M-$8.76M-$996K-$3.5M-$3.2M-$1.83M
EBITDA$3.45M-$2.54M-$8.32M-$10.66M$1.87M-$1.22M-$4.82M-$1.03M
Basic earnings per share-$0.17-$1.20-$0.53-$0.49-$0.06-$0.20-$0.18-$0.10
Diluted earnings per share-$0.17-$1.20-$0.53-$0.49-$0.06-$0.20-$0.18-$0.11

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Archer Daniels Q3 Earnings Coming Up: Here's What Lies Ahead

Archer Daniels Midland (ADM) is expected to report Q3 2026 earnings of $1.63 per share (up 77.2% YoY) and revenues of $22.7B (up 11.3% YoY) on November 3. Strong biofuel margins, robust ethanol demand, and improving Nutrition segment performance are expected to drive results, though weakness in liquid sweeteners and refined product margin pressures present headwinds. The company's Earnings ESP is 0.00% with a Zacks Rank #3.

Zacks Investment Research

Mission Produce vs. Limoneira: Which Agribusiness Stock Has the Edge?

Mission Produce (AVO) and Limoneira (LMNR) represent two different strategies in fresh produce. AVO is scaling through multi-origin sourcing and the Calavo acquisition, targeting $30M+ in synergies, while LMNR is pursuing cost optimization and asset monetization. AVO appears better positioned with stronger market share, better recent stock performance, cheaper valuation, and more favorable fiscal 2027 earnings growth, earning a Zacks Rank #2 (Buy) versus LMNR's Rank #4 (Sell).

Zacks Investment Research

Limoneira (LMNR) Misses Q3 Earnings and Revenue Estimates

Limoneira reported quarterly earnings of $0.02 per share, significantly missing the consensus estimate of $0.19 per share, representing an 89.47% earnings surprise. Revenues also fell short at $43.81 million versus the expected amount. The company received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market. The Agriculture - Operations industry ranks in the bottom 33% of Zacks industries.

Benzinga

Stock Market Today: S&P 500, Dow Futures Pare Gains As Street Awaits Delayed Q3 GDP Report— Parsons, ZIM, Trump Media & Technology In Focus (UPDATED)

U.S. stock futures pared earlier gains on Tuesday as investors await delayed Q3 GDP and durable goods reports. Major indices showed mixed performance with SPY and QQQ slightly lower in premarket trading. Key movers included Parsons (contract award), ZIM (acquisition proposals), Trump Media (Bitcoin purchase), and XMax (public offering). Markets are pricing an 80.1% likelihood of unchanged Fed rates, with a truncated trading week ahead.

The Motley Fool

Limoneira Posts 25% Revenue Drop in Q3

Limoneira reported a challenging third quarter with 25% revenue decline, sharp earnings drop, and significant pressures in its lemon and avocado businesses. Despite difficulties, management remains confident in full-year guidance and strategic partnerships.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Dec 30, 2025$0.075Jan 16, 2026recurring
Oct 6, 2025$0.075Oct 17, 2025recurring
Jul 7, 2025$0.075Jul 18, 2025recurring
Mar 31, 2025$0.075Apr 11, 2025recurring
Dec 30, 2024$0.075Jan 15, 2025recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Apr 8, 201010-for-1forward split